Yrjö E K Wichmann Email and Phone Number

My private consulting and investment company. Focused on tailored consulting and advisory work in the areas of strategy, corporate development, financing and fundraising.

Dasos Capital Oy acts as an investment advisor for Dasos Timberland Fund I, a private equity fund investing in sustainable timberland investments in Europe and emerging markets. The Fund's investors include Finnish and other European pension funds and endowments, family offices and other investors. Dasos follows valuation and reporting standards of EVCA and FVCA with the asset valuation being based on IFRS-standards and Lux-GAAP. Dasos Timberland Fund I is regulated by Commission de Surveillance du Secteur Financier (CSSF) of Luxembourg.

Bioretec Ltd is a Finnish, high-tech medical technology company that manufactures and develops advanced bioabsorbable (resorbable) implants and device solutions for various fields of surgery for global markets.

Innovation board advises the Rector and the Board of the university in matters related to commercialisation of university research as well as start-up activities.

The focus of Chip-Man Technologies Ltd. is to provide researchers with tools that will enable them to study live cell behaviour in an optimised and stable environment and analyse the findings automatically. The products are used globally, supporting the research efforts of scientists in areas such as cell biology, functional genomics, drug discovery, in vitro fertilisation, in vitro toxicology and regenerative medicine.

IP Finland, a fully owned subsidiary of IP Europe, brings value to academic expertise through commercialisation proficiency. We discover the underlying business potential in research results and intellectual property, and turn that potential into profitable reality. The formation of spin-out companies is our main commercialisation channel. Through our shareholders we also access a vast national and international technology transfer network which provides industrial licensing or technology aggregation opportunities. Our long-term partnerships with universities and research institutes provide a pool of continuous high-quality deal flow. Our drive for success lies at the core of our partnerships. Our skills in bridging academic and business expertise increases the value of research-based business ideas and IP, and thus helps create prosperity and new assets for our partnering universities and their researchers.

Business responsibility of the Diagnostics -division including research, development, commercialisation, marketing, distribution and sales of diagnostic products in the gastro-intestinal track -area.

Fundraising for CapMan Real Estate funds, CapMan Russia -fund, CapMan Buyout IX -fund, CapMan Public Market -fund and CapMan Life Science IV -fund.

Responsible of primarily Finnish investments in CapMan's Life Science Venture business unit. Participation of several exits including the IPO of Inion Ltd to LSE main list in Dec. 2004

Board member also chairman for a period, advisor to the founders

Board member with primary focus on supporting management in preparations and completion of an IPO to the main list in London Stock Exchange.

CFO, responsibility of financing, IPO preparations, legal matters.

Senior corporate finance officer. Sector responsibility: life science -industry financing. Functional responsibility: valuation. Several IPO's, several private placements and M&A transactions

Sector analyst for Metal and Engineering industries. Deputy analyst for Forest industry.

Conducted an extensive project to bring the accounting systems in par with the expanding operations of the rapidly growing company.